Telecia brings 20 years of experience in the biopharmaceutical industry, with 17 years primarily focused on ophthalmic diseases. Prior to joining Visus, Telecia was an Associate Director in Site Management for AbbVie and Allergan where she was responsible for strategizing, leading, and coordinating site management activities for both insourced and outsourced studies across several global programs, including AMD, DME, Retinitis Pigmentosa, LCA 10, Glaucoma, Dry Eye, Presbyopia and Geographic Atrophy. During her time at Allergan, she supported the development and approval of ophthalmic products for the front and back of the eye, including DURYSTA™, XEN® Gel Stent and OZURDEX®. Telecia also served as the Eye Care Subject Matter Expert for Site Management and Monitoring and the SME for PMDA inspections. During this time, Telecia facilitated the standardization of therapeutic area training and assisted with eCRFs standardization for utilization across the ophthalmology program. Her expertise includes CRO oversight, facilitating and implementing risk mitigation strategies and inspection readiness. Telecia holds a MS in Biology from Louisiana Tech University and a BS in Biology from Grambling State University.